Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exjade in transfusion-dependent chronic anaemias with iron overload
2007-004008-10Phase 4Completed
- Sponsor
- Novartis
- Start
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of deferasirox in transfusional hemosiderosis, myelodysplastic syndrome (MDS) and beta thalassemia major, sponsored by Novartis. Started Oct 2007; status: completed.
02
Drugs
deferasirox
03
Conditions
transfusional hemosiderosismyelodysplastic syndrome (MDS)beta thalassemia major
Beyond the preview
Go deeper on 2007-004008-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004008-10.